Financing - March 14, 2022
Umeå Biotech companies raised 301 million SEK last year
Companies and alumni from Umeå Biotech Incubator (UBI) raised 301 million SEK in capital investment and grants in 2021. This is a huge increase of 243 million SEK compared to the previous year, states Umeå Biotech Incubator. “It’s an absolutely fantastic amount. We work hard to help companies attract investment, so it is clear that […]
Financing - February 23, 2022
Coripharma secures 24.5 million EUR in funding
Coripharma has secured equity funding to further support its future growth through research and development of generic pharmaceutical products in addition to increased commercial outreach. The financing round is in line with the company’s previously communicated plans and attracted significant interest from large institutional investors, including Icelandic pension funds, as well as receiving strong support […]
Collaboration - February 23, 2022
Desupervised and Red Glead Discovery receive R&D grant
The two companies receive a Eurostars R&D grant to deliver AId, a novel artificial intelligence-based tool for drug discovery. In a strategic partnership between Desupervised and Red Glead Discovery the companies have joined forces to create AI-based solutions enabling companies to reduce cost and time in small molecule drug research and development, they state. “While […]
Business article - February 7, 2022
NNF expands its innovation grants to applicants from any Nordic country
Until 2021, only researchers based in Denmark were eligible to receive the Novo Nordisk Foundation (NNF)’s grants under the Distinguished Innovator programme, but from 2022 researchers in any Nordic country (Denmark, Finland, Iceland, Norway and Sweden) are eligible. These grants support research within life science and aim to stimulate innovation and entrepreneurship at universities by […]
Financing - January 31, 2022
The University of Copenhagen and Eir Ventures establish investment company
University of Copenhagen (UCPH) and Eir Ventures, a life science focused venture fund, have established a limited company with the main aim of investing in the University’s own spin-out companies. It is the first time that a Danish university establishes an investment company of this kind. UCPH Ventures The newly-established investment company, UCPH Ventures, will […]
Biotech Business - January 19, 2022
Elicera Therapeutics secures 5 million SEK
Elicera Therapeutics has announced that Vinnova has granted the company and its project partners 5 million SEK in grants to develop an automated process for CAR T-cell manufacturing. Elicera Therapeutics and its collaborators at Karolinska Institute and their production unit, Vecura at Karolinska Sjukhuset, Uppsala University and Akademiska Sjukhuset in Uppsala are preparing for a […]
